Clinical Trials in Illinois

Showing 5341-5360 of 19,692 trials

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

NCT04668339

This is a Phase 2, randomized, placebo-controlled, and observer-blind study in healthy adults. The study will evaluate the safety, tolerability, and immunogenicity of the SARS-CoV-2 RNA vaccine candidate against COVID-19: As 2 doses (at two different dose levels), separated by 28 days or as 1 dose In adults 18 years of age and older

Covid19SARS-CoV InfectionCorona Virus Infection

Arcturus Therapeutics, Inc.581 participantsStarted Jan 2021

Chandler, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +12 more locations

COMPLETEDPhase 2122 miles

A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

NCT05113771

This study was conducted as a randomized, double-blind, placebo-controlled, multi-center Phase 2b study. Approximately 180 subjects with treatment resistant depression who meet all eligibility criteria will be enrolled. The primary endpoint is to demonstrate liafensine is superior to placebo in DGM4 positive patients with TRD.

Treatment Resistant Depression

Denovo Biopharma LLC197 participantsStarted Jun 2022

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Garden Grove, California, United States +42 more locations

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

Find Trials by Condition in Illinois

Early Integrated Telehealth Versus In-Person Palliative Care for Patients With Lung Cancer

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

7-week Study With CT-155 in People With Schizophrenia

Functional and Non-Functional CSF Shunt Flow Measured With a Second-Generation Wireless Thermal Device

The Dragon PLC Trial (DRAGON-PLC)

A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)

Dose-Ranging Study of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease (STAAR)

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors

Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma

Cognition and Imaging With Tigertriever

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

Pulmonary Embolism International THrOmbolysis Study-3

Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics